Ironwood Pharmaceuticals, Inc. IRWD

4.13 (0.06) (1.43%) as of 25 Sep
Market cap
$692.4M
P/E
5.2×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
21.38 0.00 0.00 10.76 3.58 17.00 0.00 0.00 0.00 0.00
P/S ratio
1.84 2.01 4.36 4.61 4.57 4.66 4.85 3.82 6.39 6.59
P/FCF ratio
4.29 6.82 10.53 6.92 7.23 10.87 545.92 0.00 0.00 0.00
P/Operating CF
7.31 46.32 53.83 23.92 29.30 35.25 75.30 142.87 (206.82) (94.04)
P/B ratio
0.00 0.00 0.00 2.90 3.12 28.99 0.00 0.00 193.50 27.05
EV/Sales
3.09 3.98 5.73 3.98 4.21 4.84 5.39 4.51 6.97 6.81
EV/EBITDA
9.11 14.72 0.00 6.50 7.46 12.87 18.36 0.00 0.00 0.00
EV/FCF
7.20 13.54 13.84 5.98 6.66 11.29 606.61 (22.45) (20.11) (62.37)
Current Ratio
1.13 4.69 0.84 30.58 4.61 15.41 7.50 2.23 4.72 4.17
Net Debt/EBITDA
3.68 5.21 (0.64) (1.03) (0.64) 0.47 1.84 (1.73) (66.00) (1.66)
Debt/Equity
(2.23) (1.94) (2.02) 0.61 0.78 6.92 (4.39) (2.11) 40.63 5.59
ROE
(8.53%) (0.27%) (654.88%) 27.83% 158.09% (693.71%) (14.85%) 302.77% (305.46%) (100.97%)
ROA
6.42% 0.21% (127.54%) 15.72% 62.68% 22.07% 5.85% (60.22%) (17.78%) (12.30%)
ROIC
57.33% 29.99% (227.77%) 39.69% 31.74% 67.89% 54.61% (218.71%) (5.09%) (24.14%)
Return on Tangible Assets
67.91% 0.59% 2,692.16% 22.99% 89.40% 22.47% 7.73% (182.69%) (44.49%) (26.39%)
Average Days of Receivables
57.61 85.05 106.45 102.64 100.60 114.65 99.89 85.24 100.54 86.41
Earnings Yield
4.68% (0.02%) (51.97%) 9.29% 27.96% 5.88% (0.77%) (21.31%) (6.25%) (4.50%)
Free Cash Flow Yield
23.29% 14.67% 9.50% 14.45% 13.83% 9.20% 0.18% (5.26%) (5.43%) (1.66%)
Free Cash Flow per Share
0.78 0.65 1.18 1.77 1.61 1.05 0.02 (0.46) (0.69) (0.90)
Book value per Share
(1.62) (1.89) (2.23) 4.23 3.73 0.39 (0.60) (1.29) 0.07 0.46
Free Cash Flow
127.01 103.41 183.15 273.63 261.63 166.99 3.80 (69.67) (103.42) (129.91)
EV/EBIT
9.29 15.03 0.00 6.53 7.51 13.19 19.21 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates